换一批
换一批Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
第一作者：
Jeeyun,Lee
第一单位：
Division of Haematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
作者：
主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);胆道肿瘤(Biliary Tract Neoplasms);胆管上皮癌(Cholangiocarcinoma);脱氧胞苷(Deoxycytidine);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);女(雌)性(Female);胆囊肿瘤(Gallbladder Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);喹唑啉类(Quinazolines)
DOI
10.1016/S1470-2045(11)70301-1
PMID
22192731
发布时间
2022-12-07
- 浏览73
The Lancet. Oncology
181-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
